doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
Type de preuves : Essai clinique | Observationnel | Animal | In vitro | Rglementaire Mechanism of Action En tant que chlateur du cuivre, le GHK-Cu module plus de 4 000 gnes humains, en rgulant la hausse ceux impliqus dans le remodelage tissulaire (par exemple, le collagne I, III) et en rgulant la baisse les voies pro-inflammatoires comme NF-B
Raffa, M
It helps to regulate blood sugar levels by increasing insulin secretion, decreasing glucagon secretion, and slowing down gastric emptying
909 Kuhre, R
Getting enough protein is vital to minimizing muscle loss on GLP-1s Fiber intake is important because GLP-1s slow down digestion